Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Remain Calm, Stay Safe, Be Prepared: Developing and Implementing a Seizure Action Plan

Activity Resources (PDF Download)

Expert faculty quote from the live webcast: "Listening to those patient clips has been really eye-opening for me, I have to say. I think the gap between what patients want, expect appropriately, and are getting is very wide and we need to deliver better. I need to listen better, understand better, and work in partnership with them." - Sheryl R. Haut, MD

Patient Resources (Video)

neuroscienceCME Live and On Demand

Premiere Date: Wednesday, November 4, 2015
11/04/2015

This activity offers CE credit for:

1. Physicians (CME)
2. Nurses (CNE)
3. Pharmacists (ACPE)
4. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Friday, November 4, 2016
Note: Credit Is No Longer Available

Faculty

Joseph I. Sirven, MD  (Moderator) Professor and Chairman Department of Neurology Mayo Clinic College of Medicine Mayo Clinic Arizona Phoenix, AZ

Patricia Dean, ARNP, MSN  Immediate Past President Epilepsy Foundation Florida Clinical Coordinator Comprephensive Epilepsy Center Nicklaus Children's Hospital Miami, FL

Sheryl R. Haut, MD  Chair, North American Commission of the International League Against Epilepsy Director, Adult Epilepsy Program Montefiore Medical Center Professor of Clinical Neurology The Saul R. Korey Department of Neurology Assistant Professor Department of Medicine (Critical Care) Albert Einstein College of Medicine Bronx , NY

Statement of Need

Of the more than three million people in the United States who have epilepsy, lack of recognition of the signs and symptoms of epilepsy limits their ability to receive an accurate diagnosis and appropriate treatment, leading to decreased quality of life for affected persons.¹ Seizure clusters, also known as acute repetitive seizures (ARS), have a particularly negative impact on quality of life and result in, often unnecessarily, high rates of emergency department utilization and increased costs.² Implementation of a Seizure Action Plan developed with active participation by patients through shared decision-making can prepare individuals and families in the event of a seizure and improve quality of life for affected individuals. A variety of tools can be used to maximize the collaborative nature of the development of a Seizure Action Plan.

This neuroscienceCME Live and On Demand webcast will feature an interactive and engaging panel of national experts addressing recognition of seizure types, tools to develop Seizure Action Plans, and patient-centered approaches to shared decision-making with the goal of optimizing long-term outcomes in individuals with epilepsy.

---

1. O'Dell C, Wheless JW, Cloyd J. The personal and financial impact of repetitive or prolonged seizures on the patient and family. J Child Neurol. 2007;22(5 Suppl):61S-70S. PMID: 17690089.
2. Caron E, Wheless CE, Patters AB, Wheless JW. The charges for seizures in the pediatric emergency room: a single center study. Pediatr Neurol. 2015;52(5):517-520. PMID: 25882079.
3. Shared Decision Making in Neurology - Adam Webb (Video Resource)

Learning Objectives

At the end of this CE activity, participants should be able to:

• Identify seizure types and the treatments that are most likely to be effective for each type.
• Promote patient’s active participation in managing and understanding their health by incorporating shared decision-making in the creation of a Seizure Action Plan for patients with epilepsy.
• Develop a Seizure Action Plan that incorporates the latest evidence regarding seizure rescue formulations.

The following learning objectives pertain only to those requesting CNE or CPE credit:

• Describe seizure types and the treatments that are most likely to be effective for each type.
• Review incorporating shared decision-making in the creation of a Seizure Action Plan for patients with epilepsy.
• Evaluate a Seizure Action Plan that incorporates the latest evidence regarding seizure rescue formations.

Financial Support

Supported by an educational grant from Upsher-Smith Laboratories, Inc.

Target Audience

Neurologists, epileptologists, epilepsy nurse specialists, physician assistants, pharmacists, and other health care professionals interested in epilepsy.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs)
Universal Activity Number: 0376-0000-15-027-L01-P (live programs)
0376-0000-15-027-H01-P (recorded programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST13039 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Sirven has disclosed that he has received grant/research support from NeuroPace, Inc. He serves as a consultant from Upsher-Smith Laboratories, Inc.; MAP Pharmaceuticals, Inc.

Ms. Dean has disclosed that she is on the speakers bureau for Cyberonics, Inc.

Dr. Haut has disclosed that she serves as a consultant for Acorda Therapeutics; Neurelis Inc.; and Upsher-Smith Laboratories, Inc.

Jeffery Helfand, DO, MS (peer reviewer) has no disclosures to report.

Kimberley Murray, RN, MS (peer reviewer) has no disclosures to report.

Catherine Murray (planning committee) has no disclosures to report.

Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.

Disclosures have been obtained from CME Outfitters staff: No disclosures to report.

Unlabeled Use Disclosure

Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).